10 20 30 40 50 60 70 80 2X4T - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER IMMUNE SYSTEM 02-FEB-10 2X4T
TITLE CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2.1 BOUND TO A TITLE 2 PEIODATE-CLEAVABLE PEPTIDE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2.1; COMPND 3 CHAIN: A, D; COMPND 4 FRAGMENT: RESIDUES 25-299; COMPND 5 SYNONYM: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA COMPND 6 CHAIN; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 10 CHAIN: B, E; COMPND 11 SYNONYM: BETA-2-MICROGLOBULIN FORM PI 5.3; COMPND 12 ENGINEERED: YES; COMPND 13 MOL_ID: 3; COMPND 14 MOLECULE: 65 KDA PHOSPHOPROTEIN; COMPND 15 CHAIN: C, F; COMPND 16 FRAGMENT: EPITOPE, RESIDUES 495-503; COMPND 17 SYNONYM: LOWER MATRIX PROTEIN PP65,64 KDA MATRIX COMPND 18 PHOSPHOPROTEIN
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 EXPRESSION_SYSTEM_STRAIN: XLI BLUE; SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 17 MOL_ID: 3; SOURCE 18 SYNTHETIC: YES; SOURCE 19 ORGANISM_SCIENTIFIC: HUMAN HERPESVIRUS 5; SOURCE 20 ORGANISM_TAXID: 10359
KEYWDS MHC CLASS I, IMMUNOGLOBULIN DOMAIN, HOST-VIRUS INTERACTION, KEYWDS 2 GLYCATION, AMYLOIDOSIS, AMYLOID, PHOTOCLEAVABLE PEPTIDE, KEYWDS 3 IMMUNE RESPONSE, IMMUNE SYSTEM
EXPDTA X-RAY DIFFRACTION
AUTHOR B.RODENKO,M.TOEBES,P.H.N.CELIE,A.PERRAKIS,T.N.M.SCHUMACHER, AUTHOR 2 H.OVAA
REVDAT 1 02-MAR-10 2X4T 0
JRNL AUTH B.RODENKO,M.TOEBES,P.H.N.CELIE,A.PERRAKIS, JRNL AUTH 2 T.N.M.SCHUMACHER,H.OVAA JRNL TITL CLASS I MAJOR HISTOCOMPATIBILITY COMPLEXES LOADED JRNL TITL 2 BY A PERIODATE TRIGGER. JRNL REF J.AM.CHEM.SOC. V. 131 12305 2009 JRNL REFN ISSN 0002-7863 JRNL PMID 19655751 JRNL DOI 10.1021/JA9037565
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH P.H.N.CELIE,M.TOEBES,B.RODENKO,H.OVAA,A.PERRAKIS, REMARK 1 AUTH 2 T.N.M.SCHUMACHER REMARK 1 TITL UV-INDUCED LIGAND EXCHANGE IN MHC CLASS I PROTEIN REMARK 1 TITL 2 CRYSTALS. REMARK 1 REF J.AM.CHEM.SOC. V. 131 12298 2009 REMARK 1 REFN ISSN 0002-7863 REMARK 1 PMID 19655750 REMARK 1 DOI 10.1021/JA9037559
REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VICENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : TWIN_LSQ_F REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.830 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.38 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.89 REMARK 3 NUMBER OF REFLECTIONS : 36785 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.1858 REMARK 3 R VALUE (WORKING SET) : 0.1839 REMARK 3 FREE R VALUE : 0.2357 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1855 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 18.8759 - 5.3705 0.93 2731 168 0.1440 0.2115 REMARK 3 2 5.3705 - 4.2791 0.94 2758 133 0.1314 0.1555 REMARK 3 3 4.2791 - 3.7430 0.94 2732 139 0.1527 0.2172 REMARK 3 4 3.7430 - 3.4029 0.94 2691 133 0.1852 0.2183 REMARK 3 5 3.4029 - 3.1602 0.94 2689 144 0.1998 0.2977 REMARK 3 6 3.1602 - 2.9747 0.92 2660 152 0.2124 0.2866 REMARK 3 7 2.9747 - 2.8262 0.92 2669 137 0.2354 0.2856 REMARK 3 8 2.8262 - 2.7035 0.93 2688 136 0.2487 0.3545 REMARK 3 9 2.7035 - 2.5997 0.93 2629 141 0.2549 0.3269 REMARK 3 10 2.5997 - 2.5102 0.93 2677 140 0.2755 0.3330 REMARK 3 11 2.5102 - 2.4319 0.92 2661 157 0.2724 0.2946 REMARK 3 12 2.4319 - 2.3625 0.93 2658 127 0.2878 0.3591 REMARK 3 13 2.3625 - 2.3004 0.94 2685 123 0.3076 0.3232 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.321 REMARK 3 B_SOL : 51.477 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 35.50 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.0 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 66.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.9060 REMARK 3 B22 (A**2) : 5.5356 REMARK 3 B33 (A**2) : -2.6296 REMARK 3 B12 (A**2) : 0.0000 REMARK 3 B13 (A**2) : -0.1416 REMARK 3 B23 (A**2) : 0.0000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: 0.107 REMARK 3 OPERATOR: -H,-K,L REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 6550 REMARK 3 ANGLE : 1.334 8866 REMARK 3 CHIRALITY : 0.125 907 REMARK 3 PLANARITY : 0.004 1149 REMARK 3 DIHEDRAL : 20.557 2360 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 6 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN A AND RESID :180) REMARK 3 ORIGIN FOR THE GROUP (A): 5.0375 3.0058 19.5794 REMARK 3 T TENSOR REMARK 3 T11: 0.4279 T22: 0.4625 REMARK 3 T33: 0.5557 T12: 0.0172 REMARK 3 T13: 0.0572 T23: 0.1773 REMARK 3 L TENSOR REMARK 3 L11: 1.1769 L22: 0.5948 REMARK 3 L33: 1.1474 L12: -0.5305 REMARK 3 L13: -0.6355 L23: -0.0561 REMARK 3 S TENSOR REMARK 3 S11: 0.1138 S12: -0.6407 S13: 0.0264 REMARK 3 S21: 0.1970 S22: 0.1499 S23: 0.6563 REMARK 3 S31: -0.0734 S32: -0.2022 S33: -0.0003 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN A AND RESID 181:275) REMARK 3 ORIGIN FOR THE GROUP (A): 36.4063 6.8389 3.7278 REMARK 3 T TENSOR REMARK 3 T11: 0.3501 T22: 0.2207 REMARK 3 T33: 0.2712 T12: 0.0347 REMARK 3 T13: 0.0356 T23: 0.0911 REMARK 3 L TENSOR REMARK 3 L11: 0.8471 L22: 0.6505 REMARK 3 L33: 0.4706 L12: 0.2304 REMARK 3 L13: 0.4434 L23: -0.2579 REMARK 3 S TENSOR REMARK 3 S11: 0.1649 S12: 0.2121 S13: 0.3402 REMARK 3 S21: 0.0507 S22: -0.2455 S23: -0.1263 REMARK 3 S31: -0.2442 S32: 0.2430 S33: 0.0003 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): 26.1994 -11.3738 11.4556 REMARK 3 T TENSOR REMARK 3 T11: 0.3603 T22: -0.1513 REMARK 3 T33: 0.4530 T12: 0.0340 REMARK 3 T13: -0.0556 T23: 0.1789 REMARK 3 L TENSOR REMARK 3 L11: 0.3489 L22: 0.5606 REMARK 3 L33: 1.9994 L12: 0.3505 REMARK 3 L13: -0.1707 L23: 0.2436 REMARK 3 S TENSOR REMARK 3 S11: 0.1286 S12: -0.2877 S13: -0.6814 REMARK 3 S21: -0.0565 S22: 0.0883 S23: 0.0669 REMARK 3 S31: 0.1180 S32: 0.3800 S33: 0.6159 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: (CHAIN D AND RESID :180) REMARK 3 ORIGIN FOR THE GROUP (A): 25.7587 38.4983 35.6223 REMARK 3 T TENSOR REMARK 3 T11: 0.3602 T22: 0.4980 REMARK 3 T33: 0.3909 T12: -0.0264 REMARK 3 T13: 0.0396 T23: -0.0926 REMARK 3 L TENSOR REMARK 3 L11: 1.3433 L22: 0.6123 REMARK 3 L33: 0.9661 L12: -0.6198 REMARK 3 L13: 0.6859 L23: -0.0099 REMARK 3 S TENSOR REMARK 3 S11: -0.0496 S12: -0.3577 S13: -0.1303 REMARK 3 S21: 0.1252 S22: 0.0447 S23: -0.3854 REMARK 3 S31: -0.0712 S32: 0.1727 S33: -0.0000 REMARK 3 TLS GROUP : 5 REMARK 3 SELECTION: (CHAIN D AND RESID 181:275) REMARK 3 ORIGIN FOR THE GROUP (A): -5.6273 34.0772 19.7843 REMARK 3 T TENSOR REMARK 3 T11: 0.3620 T22: 0.5486 REMARK 3 T33: 0.4978 T12: -0.0700 REMARK 3 T13: -0.0215 T23: -0.1459 REMARK 3 L TENSOR REMARK 3 L11: 0.5031 L22: 0.4601 REMARK 3 L33: 0.3108 L12: 0.0336 REMARK 3 L13: -0.3518 L23: 0.0605 REMARK 3 S TENSOR REMARK 3 S11: 0.0601 S12: 0.2926 S13: -0.2300 REMARK 3 S21: -0.1099 S22: -0.1193 S23: 0.5256 REMARK 3 S31: 0.1640 S32: -0.4010 S33: -0.0001 REMARK 3 TLS GROUP : 6 REMARK 3 SELECTION: CHAIN E REMARK 3 ORIGIN FOR THE GROUP (A): 5.2121 52.5328 26.4701 REMARK 3 T TENSOR REMARK 3 T11: 0.4130 T22: 0.4019 REMARK 3 T33: 0.3246 T12: -0.0410 REMARK 3 T13: 0.0867 T23: -0.0869 REMARK 3 L TENSOR REMARK 3 L11: 0.4736 L22: 0.6234 REMARK 3 L33: 0.4271 L12: 0.0978 REMARK 3 L13: 0.3687 L23: -0.2090 REMARK 3 S TENSOR REMARK 3 S11: 0.0492 S12: 0.0080 S13: 0.1804 REMARK 3 S21: 0.0304 S22: -0.0088 S23: 0.0253 REMARK 3 S31: -0.2522 S32: -0.1462 S33: -0.0001 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2X4T COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-FEB-10. REMARK 100 THE PDBE ID CODE IS EBI-42691.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97790 REMARK 200 MONOCHROMATOR : NI FILTER REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL PSI PILATUS 6M REMARK 200 DETECTOR MANUFACTURER : PSI REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 37003 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.20 REMARK 200 RESOLUTION RANGE LOW (A) : 37.50 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.7 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 3.1 REMARK 200 R MERGE (I) : 0.06 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.90 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.42 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.2 REMARK 200 R MERGE FOR SHELL (I) : 0.51 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.40 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: PDB ENTRY 1EEY REMARK 200 REMARK 200 REMARK: NONE
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.4 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M MES PH 6.5, 22% PEG1500
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 42.75800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5360 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18530 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18770 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN E 17 NH2 ARG E 97 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 NE2 HIS A 260 NE2 GLN B 89 1655 1.89 REMARK 500 OG SER B 20 OE1 GLU D 58 1646 2.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 50 C - N - CD ANGL. DEV. = -18.2 DEGREES REMARK 500 PRO D 57 C - N - CD ANGL. DEV. = -14.3 DEGREES REMARK 500 PRO D 57 CA - N - CD ANGL. DEV. = -11.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -122.66 49.07 REMARK 500 GLN A 54 43.66 -98.23 REMARK 500 TRP A 107 6.42 81.72 REMARK 500 PHE A 109 140.19 -31.98 REMARK 500 LEU A 110 -70.07 -122.25 REMARK 500 TYR A 123 -65.66 -124.82 REMARK 500 ARG A 131 18.25 -150.14 REMARK 500 ASP A 137 -152.26 -138.38 REMARK 500 LYS A 176 -29.85 -39.51 REMARK 500 SER A 195 -146.27 -142.25 REMARK 500 ASP A 220 19.62 55.56 REMARK 500 ILE B 1 144.72 -37.08 REMARK 500 PRO B 32 -161.55 -74.71 REMARK 500 GLU B 50 -168.19 -70.29 REMARK 500 SER B 57 -167.47 -115.25 REMARK 500 TRP B 60 -2.66 78.19 REMARK 500 ASP D 29 -127.92 40.12 REMARK 500 GLN D 43 25.90 40.59 REMARK 500 GLN D 54 41.48 -99.78 REMARK 500 HIS D 114 113.65 -160.79 REMARK 500 TYR D 123 -74.65 -116.66 REMARK 500 SER D 195 -139.67 -153.45 REMARK 500 GLN E 2 111.72 -160.12 REMARK 500 PRO E 32 -166.37 -69.79 REMARK 500 LYS E 48 57.25 -91.13 REMARK 500 TRP E 60 -3.65 76.98 REMARK 500 PRO E 90 126.38 -39.84 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES E1099 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MES B1099 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D1276 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL D1277 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A1276
REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1UQS RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1B WITH A REMARK 900 BOUND BACTERIAL GLYCOLIPID REMARK 900 RELATED ID: 1BD2 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR B7, REMARK 900 VIRAL PEPTIDE (TAX) AND MHC CLASS I REMARK 900 MOLECULE HLA-A 0201 REMARK 900 RELATED ID: 2ESV RELATED DB: PDB REMARK 900 STRUCTURE OF THE HLA-E-VMAPRTLIL/KK50.4 REMARK 900 TCR COMPLEX REMARK 900 RELATED ID: 2AK4 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF SB27 TCR IN COMPLEX REMARK 900 WITH HLA-B*3508-13MER PEPTIDE REMARK 900 RELATED ID: 1YPZ RELATED DB: PDB REMARK 900 IMMUNE RECEPTOR REMARK 900 RELATED ID: 1IM3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN CYTOMEGALOVIRUS REMARK 900 PROTEIN US2BOUND TO THE MHC CLASS I REMARK 900 MOLECULE HLA-A2/TAX REMARK 900 RELATED ID: 1UXW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED REMARK 900 WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE REMARK 900 (LMP2) OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1I7U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN REMARK 900 COMPLEX WITH PEPTIDEP1049-6V REMARK 900 RELATED ID: 1C16 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF THE GAMMA/ REMARK 900 DELTA T CELL LIGAND T22 REMARK 900 RELATED ID: 1HSA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN HLA- REMARK 900 B(ASTERISK)2705 REMARK 900 RELATED ID: 1GZP RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH GM2 GANGLIOSIDE REMARK 900 RELATED ID: 2AXF RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T REMARK 900 CELL EPITOPE ISCONTROLLED BY ITS MHC-BOUND REMARK 900 CONFORMATION REMARK 900 RELATED ID: 2BNQ RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED REMARK 900 IMMUNOGENICITY OF T CELL VACCINES REMARK 900 RELATED ID: 1W72 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A1:MAGE-A1 IN REMARK 900 COMPLEX WITH FAB-HYB3 REMARK 900 RELATED ID: 2JCC RELATED DB: PDB REMARK 900 AH3 RECOGNITION OF MUTANT HLA-A2 W167A REMARK 900 RELATED ID: 2BCK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*2402 COMPLEXED REMARK 900 WITH A TELOMERASEPEPTIDE REMARK 900 RELATED ID: 1DE4 RELATED DB: PDB REMARK 900 HEMOCHROMATOSIS PROTEIN HFE COMPLEXED WITH REMARK 900 TRANSFERRINRECEPTOR REMARK 900 RELATED ID: 2VLK RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN REMARK 900 IMMUNODOMINANT T-CELL RECEPTOR ARE REMARK 900 PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 1EXU RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN MHC-RELATED REMARK 900 FC RECEPTOR REMARK 900 RELATED ID: 1QRN RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN A6 TCR COMPLEXED REMARK 900 WITH HLA-A2 BOUND TO ALTERED HTLV-1 REMARK 900 TAX PEPTIDE P6A REMARK 900 RELATED ID: 2HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN AW REMARK 900 68.1 (HLA-AW 68.1, HUMAN LEUCOCYTE REMARK 900 ANTIGEN) REMARK 900 RELATED ID: 1MHE RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR REMARK 900 HISTOCOMPATIBILITY COMPLEX MOLECULE HLA-E REMARK 900 RELATED ID: 1IM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN NATURAL REMARK 900 KILLER CELLINHIBITORY RECEPTOR KIR2DL1 BOUND REMARK 900 TO ITS MHC LIGAND HLA-CW4 REMARK 900 RELATED ID: 1EEZ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA-A2.1 REMARK 900 COMPLEXED TOGP2 PEPTIDE VARIANT(I2L/V5L) REMARK 900 RELATED ID: 1JHT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN REMARK 900 COMPLEX WITH ANONAMERIC ALTERED PEPTIDE LIGAND REMARK 900 (ALGIGILTV) FROM THE MART-1/MELAN-A. REMARK 900 RELATED ID: 1QQD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-CW4, A LIGAND FOR REMARK 900 THE KIR2D NATURAL KILLER CELL INHIBITORY REMARK 900 RECEPTOR REMARK 900 RELATED ID: 1QR1 RELATED DB: PDB REMARK 900 POOR BINDING OF A HER-2/NEU EPITOPE (GP2 REMARK 900 ) TO HLA-A2.1 IS DUE TO A LACK OF REMARK 900 INTERACTIONS IN THE CENTER OF THE PEPTIDE REMARK 900 RELATED ID: 1ZS8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MURINE MHC CLASS REMARK 900 IB MOLECULE M10.5 REMARK 900 RELATED ID: 1HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2 ( REMARK 900 HLA-A2, HUMAN LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1JGD RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO DECA-PEPTIDE S10R REMARK 900 RELATED ID: 1I1Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( REMARK 900 HLA-A2.1) COMPLEXED WITH BETA 2- REMARK 900 MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 1VGK RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF CLASS I MAJOR REMARK 900 HISTOCOMPATIBILITYCOMPLEX, H-2KD AT 2.0 A REMARK 900 RESOLUTION REMARK 900 RELATED ID: 1AGE RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG REMARK 900 PEPTIDE (GGKKKYRL - 7R MUTATION) REMARK 900 RELATED ID: 1UR7 RELATED DB: PDB REMARK 900 MOLECULAR REFINEMENT OF ANTI-HLA-A2 USING REMARK 900 LIGHT CHAIN SHUFFLING: A STRUCTURAL MODEL REMARK 900 FOR HLA ANTIBODY BINDING REMARK 900 RELATED ID: 1HHG RELATED DB: PDB REMARK 900 RELATED ID: 1S9X RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 REMARK 900 EPITOPE ANALOGUE,SLLMWITQA, IN COMPLEX WITH REMARK 900 HLA-A2 REMARK 900 RELATED ID: 1A9E RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE REMARK 900 BOUND TO HLA-B 3501 DUE TO NONSTANDARD REMARK 900 POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 1DUZ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA REMARK 900 -A 0201) INCOMPLEX WITH A NONAMERIC PEPTIDE REMARK 900 FROM HTLV-1 TAX PROTEIN REMARK 900 RELATED ID: 2CLR RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA REMARK 900 -A 0201) COMPLEXED WITH A DECAMERIC PEPTIDE REMARK 900 FROM CALRETICULIN REMARK 900 RELATED ID: 3HLA RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN A2. REMARK 900 1 (HLA-A2.1 HUMAN LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1M05 RELATED DB: PDB REMARK 900 HLA B8 IN COMPLEX WITH AN EPSTEIN BARR REMARK 900 VIRUS DETERMINANT REMARK 900 RELATED ID: 1TVB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MELANOMA ANTIGEN GP100( REMARK 900 209-217) BOUNDTO HUMAN CLASS I MHC HLA- REMARK 900 A2 REMARK 900 RELATED ID: 2V2W RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL REMARK 900 CHANGES DURING TCR ENGAGEMENT REMARK 900 RELATED ID: 1ONQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH REMARK 900 A SULFATIDE REMARK 900 RELATED ID: 2VLR RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN REMARK 900 IMMUNODOMINANT T-CELL RECEPTOR ARE REMARK 900 PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 1A1N RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*3501 COMPLEXED WITH REMARK 900 PEPTIDE VPLRPMTYFROM THE NEF PROTEIN (75- REMARK 900 82) OF HIV1 REMARK 900 RELATED ID: 2BVO RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- REMARK 900 PEPTIDE COMPLEXES AND IDENTIFICATION OF REMARK 900 RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG REMARK 900 -TERM NON-PROGRESSION REMARK 900 RELATED ID: 1LP9 RELATED DB: PDB REMARK 900 XENOREACTIVE COMPLEX AHIII 12.2 TCR BOUND REMARK 900 TO P1049/HLA-A2.1 REMARK 900 RELATED ID: 1ZSD RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*3501 PRESENTING REMARK 900 AN 11-MER EBVANTIGEN EPLPQGQLTAY REMARK 900 RELATED ID: 1M6O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA B*4402 IN COMPLEX REMARK 900 WITH HLADPA*0201 PEPTIDE REMARK 900 RELATED ID: 1HHK RELATED DB: PDB REMARK 900 RELATED ID: 1ZT4 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF HUMAN CD1D WITH REMARK 900 AND WITHOUT ALPHA-GALACTOSYLCERAMIDE REMARK 900 RELATED ID: 1HSB RELATED DB: PDB REMARK 900 CLASS I HISTOCOMPATIBILITY ANTIGEN AW68.1 ( REMARK 900 LEUCOCYTE ANTIGEN) REMARK 900 RELATED ID: 1CE6 RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH A REMARK 900 SENDAI VIRUSNUCLEOPROTEIN PEPTIDE REMARK 900 RELATED ID: 1X7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*1101 WITH SARS REMARK 900 NUCLEOCAPSIDPEPTIDE REMARK 900 RELATED ID: 1PY4 RELATED DB: PDB REMARK 900 BETA2 MICROGLOBULIN MUTANT H31Y DISPLAYS HINTS REMARK 900 FOR AMYLOIDFORMATIONS REMARK 900 RELATED ID: 1SYV RELATED DB: PDB REMARK 900 HLA-B*4405 COMPLEXED TO THE DOMINANT SELF REMARK 900 LIGAND EEFGRAYGF REMARK 900 RELATED ID: 2J8U RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION REMARK 900 OF MHC MUTATION. REMARK 900 RELATED ID: 1SYS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA, B*4403, AND REMARK 900 PEPTIDE EEPTVIKKY REMARK 900 RELATED ID: 1OGT RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED REMARK 900 WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE REMARK 900 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408 REMARK 900 ) REMARK 900 RELATED ID: 1CG9 RELATED DB: PDB REMARK 900 COMPLEX RECOGNITION OF THE SUPERTYPIC BW6- REMARK 900 DETERMINANT ONHLA-B AND-C MOLECULES BY THE REMARK 900 MONOCLONAL ANTIBODY SFR8-B6 REMARK 900 RELATED ID: 1P7Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2 BOUND TO LIR- REMARK 900 1, A HOST ANDVIRAL MHC RECEPTOR REMARK 900 RELATED ID: 1Q94 RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH REMARK 900 IMMUNODOMINANTNONAMER AND DECAMER HIV-1 REMARK 900 EPITOPES CLEARLY REVEAL THEPRESENCE OF A REMARK 900 MIDDLE ANCHOR RESIDUE REMARK 900 RELATED ID: 1JNJ RELATED DB: PDB REMARK 900 NMR SOLUTION STRUCTURE OF THE HUMAN BETA2- REMARK 900 MICROGLOBULIN REMARK 900 RELATED ID: 1AGB RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG REMARK 900 PEPTIDE (GGRKKYKL - 3R MUTATION) REMARK 900 RELATED ID: 2D31 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF DISULFIDE-LINKED HLA-G REMARK 900 DIMER REMARK 900 RELATED ID: 1AQD RELATED DB: PDB REMARK 900 HLA-DR1 (DRA, DRB1 0101) HUMAN CLASS II REMARK 900 HISTOCOMPATIBILITYPROTEIN (EXTRACELLULAR DOMAIN) REMARK 900 COMPLEXED WITH ENDOGENOUSPEPTIDE REMARK 900 RELATED ID: 1XZ0 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CD1A IN COMPLEX WITH REMARK 900 A SYNTHETICMYCOBACTIN LIPOPEPTIDE REMARK 900 RELATED ID: 1LDS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MONOMERIC HUMAN BETA-2 REMARK 900 -MICROGLOBULIN REMARK 900 RELATED ID: 1TVH RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MODIFIED MELANOMA ANTIGEN REMARK 900 GP100(209-T2M) BOUND TO HUMAN CLASS I REMARK 900 MHC HLA-A2 REMARK 900 RELATED ID: 1HHH RELATED DB: PDB REMARK 900 RELATED ID: 1XR8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN REMARK 900 COMPLEX WITH PEPTIDESFROM HUMAN UBCH6 AND REMARK 900 EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2BSS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF REMARK 900 THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED REMARK 900 TO HLA-B2705 REMARK 900 RELATED ID: 1A1M RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B*5301 COMPLEXED WITH REMARK 900 PEPTIDETYPDINQML FROM GAG PROTEIN OF HIV2 REMARK 900 RELATED ID: 1E28 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 REMARK 900 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM2 REMARK 900 (TAFTIPSI) REMARK 900 RELATED ID: 2BVP RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- REMARK 900 PEPTIDE COMPLEXES AND IDENTIFICATION OF REMARK 900 RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG REMARK 900 -TERM NON-PROGRESSION REMARK 900 RELATED ID: 2V2X RELATED DB: PDB REMARK 900 T CELL CROSS-REACTIVITY AND CONFORMATIONAL REMARK 900 CHANGES DURING TCR ENGAGEMENT. REMARK 900 RELATED ID: 1XR9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF HLA-B*1501 IN REMARK 900 COMPLEX WITH PEPTIDESFROM HUMAN UBCH6 AND REMARK 900 EPSTEIN-BARR VIRUS EBNA-3 REMARK 900 RELATED ID: 2GJ6 RELATED DB: PDB REMARK 900 THE COMPLEX BETWEEN TCR A6 AND HUMAN CLASS REMARK 900 I MHC HLA-A2WITH THE MODIFIED HTLV-1 REMARK 900 TAX (Y5K-4-[3-INDOLYL]-BUTYRICACID) PEPTIDE REMARK 900 RELATED ID: 1QLF RELATED DB: PDB REMARK 900 MHC CLASS I H-2DB COMPLEXED WITH REMARK 900 GLYCOPEPTIDE K3G REMARK 900 RELATED ID: 1EFX RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE HUMAN REMARK 900 NATURAL KILLER CELL RECEPTOR KIR2DL2 AND A REMARK 900 CLASS I MHC LIGAND HLA-CW3 REMARK 900 RELATED ID: 2AV1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE REMARK 900 BOUND TO HUMANCLASS I MHC HLA-A2 WITH REMARK 900 THE E63Q AND K66A MUTATIONS IN THEHEAVY REMARK 900 CHAIN. REMARK 900 RELATED ID: 1TMC RELATED DB: PDB REMARK 900 TRUNCATED HUMAN CLASS I HISTOCOMPATIBILITY REMARK 900 ANTIGEN HLA-AW68 COMPLEXED WITH A DECAMERIC REMARK 900 PEPTIDE (EVAPPEYHRK) REMARK 900 RELATED ID: 1QSF RELATED DB: PDB REMARK 900 STRUCTURE OF A6-TCR BOUND TO HLA-A2 REMARK 900 COMPLEXED WITH ALTERED HTLV-1 TAX PEPTIDE REMARK 900 Y8A REMARK 900 RELATED ID: 1JGE RELATED DB: PDB REMARK 900 HLA-B*2705 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1DUY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201/OCTAMERIC TAX REMARK 900 PEPTIDE COMPLEX REMARK 900 RELATED ID: 1KPR RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR REMARK 900 HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E REMARK 900 RELATED ID: 2HJL RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 REMARK 900 PEPTIDE REMARK 900 RELATED ID: 1QEW RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA REMARK 900 -A 0201)COMPLEX WITH A NONAMERIC PEPTIDE REMARK 900 FROM MELANOMA-ASSOCIATEDANTIGEN 3 (RESIDUES REMARK 900 271-279) REMARK 900 RELATED ID: 1W0V RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED REMARK 900 WITH THE SELF-PEPTIDE TIS FROM EGF- REMARK 900 RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1K5N RELATED DB: PDB REMARK 900 HLA-B*2709 BOUND TO NONA-PEPTIDE M9 REMARK 900 RELATED ID: 1AO7 RELATED DB: PDB REMARK 900 COMPLEX BETWEEN HUMAN T-CELL RECEPTOR, VIRAL REMARK 900 PEPTIDE (TAX), AND HLA-A 0201 REMARK 900 RELATED ID: 1XH3 RELATED DB: PDB REMARK 900 CONFORMATIONAL RESTRAINTS AND FLEXIBILITY OF REMARK 900 14-MERICPEPTIDES IN COMPLEX WITH HLA-B* REMARK 900 3501 REMARK 900 RELATED ID: 2BNR RELATED DB: PDB REMARK 900 STRUCTURAL AND KINETIC BASIS FOR HIGHTENED REMARK 900 IMMUNOGENICITY OF T CELL VACCINES REMARK 900 RELATED ID: 2BST RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF REMARK 900 THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED REMARK 900 TO HLA-B2705 REMARK 900 RELATED ID: 1MI5 RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF LC13 TCR IN REMARK 900 COMPLEX WITH HLAB8-EBVPEPTIDE COMPLEX REMARK 900 RELATED ID: 2H26 RELATED DB: PDB REMARK 900 HUMAN CD1B IN COMPLEX WITH ENDOGENOUS REMARK 900 PHOSPHATIDYLCHOLINEAND SPACER REMARK 900 RELATED ID: 1S9Y RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 REMARK 900 EPITOPE ANALOGUE,SLLMWITQS, IN COMPLEX WITH REMARK 900 HLA-A2 REMARK 900 RELATED ID: 1A1O RELATED DB: PDB REMARK 900 MHC CLASS I MOLECULE B5301 COMPLEXED WITH REMARK 900 PEPTIDE LS6 (KPIVQYDNF) FROM THE MALARIA REMARK 900 PARASITE P. FALCIPARUM REMARK 900 RELATED ID: 2A83 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED REMARK 900 WITH THE GLUCAGONRECEPTOR (GR) PEPTIDE ( REMARK 900 RESIDUES 412-420) REMARK 900 RELATED ID: 1AGF RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG REMARK 900 PEPTIDE (GGKKRYKL - 5R MUTATION) REMARK 900 RELATED ID: 1OGA RELATED DB: PDB REMARK 900 A STRUCTURAL BASIS FOR IMMUNODOMINANT HUMAN REMARK 900 T-CELL RECEPTOR RECOGNITION. REMARK 900 RELATED ID: 2F8O RELATED DB: PDB REMARK 900 A NATIVE TO AMYLOIDOGENIC TRANSITION REGULATED REMARK 900 BY ABACKBONE TRIGGER REMARK 900 RELATED ID: 2CII RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF H-2DB COMPLEXED REMARK 900 WITH A PARTIAL PEPTIDE EPITOPE SUGGESTS AN REMARK 900 MHC CLASS I ASSEMBLY-INTERMEDIATE REMARK 900 RELATED ID: 1I7R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN REMARK 900 COMPLEX WITH PEPTIDEP1058 REMARK 900 RELATED ID: 1JF1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A2*0201 IN REMARK 900 COMPLEX WITH ADECAMERIC ALTERED PEPTIDE LIGAND REMARK 900 FROM THE MART-1/MELAN-A REMARK 900 RELATED ID: 2C7U RELATED DB: PDB REMARK 900 CONFLICTING SELECTIVE FORCES AFFECT CD8 T- REMARK 900 CELL RECEPTOR CONTACT SITES IN AN HLA-A2 REMARK 900 IMMUNODOMINANT HIV EPITOPE. REMARK 900 RELATED ID: 2F74 RELATED DB: PDB REMARK 900 MURINE MHC CLASS I H-2DB IN COMPLEX WITH REMARK 900 HUMAN B2-MICROGLOBULIN AND LCMV-DERIVED REMARK 900 IMMUNODMINANT PEPTIDE GP33 REMARK 900 RELATED ID: 1E27 RELATED DB: PDB REMARK 900 NONSTANDARD PEPTIDE BINDING OF HLA-B*5101 REMARK 900 COMPLEXED WITH HIV IMMUNODOMINANT EPITOPE KM1 REMARK 900 (LPPVVAKEI) REMARK 900 RELATED ID: 1W0W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED REMARK 900 WITH THE SELF-PEPTIDE TIS FROM EGF- REMARK 900 RESPONSE FACTOR 1 REMARK 900 RELATED ID: 1GZQ RELATED DB: PDB REMARK 900 CD1B IN COMPLEX WITH PHOPHATIDYLINOSITOL REMARK 900 RELATED ID: 1UXS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2705 COMPLEXED REMARK 900 WITH THE LATENT MEMBRANE PROTEIN 2 PEPTIDE REMARK 900 (LMP2)OF EPSTEIN-BARR VIRUS REMARK 900 RELATED ID: 1AKJ RELATED DB: PDB REMARK 900 COMPLEX OF THE HUMAN MHC CLASS I REMARK 900 GLYCOPROTEIN HLA-A2 ANDTHE T CELL CORECEPTOR REMARK 900 CD8 REMARK 900 RELATED ID: 2HJK RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B5703 AND HIV-1 REMARK 900 PEPTIDE REMARK 900 RELATED ID: 2VB5 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF W60G MUTANT OF HUMAN REMARK 900 BETA2-MICROGLOBULIN REMARK 900 RELATED ID: 1AGD RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG REMARK 900 PEPTIDE (GGKKKYKL - INDEX PEPTIDE) REMARK 900 RELATED ID: 1R3H RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF T10 REMARK 900 RELATED ID: 1EEY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE DETERMINATION OF HLA A2 REMARK 900 COMPLEXED TOPEPTIDE GP2 WITH THE SUBSTITUTION REMARK 900 (I2L/V5L/L9V) REMARK 900 RELATED ID: 1I7T RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF CLASS I MHC A2 IN REMARK 900 COMPLEX WITH PEPTIDEP1049-5V REMARK 900 RELATED ID: 1I4F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A*0201/MAGE-A4- REMARK 900 PEPTIDE COMPLEX REMARK 900 RELATED ID: 1YDP RELATED DB: PDB REMARK 900 1.9A CRYSTAL STRUCTURE OF HLA-G REMARK 900 RELATED ID: 2VLL RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN REMARK 900 IMMUNODOMINANT T-CELL RECEPTOR ARE REMARK 900 PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 2BSR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES AND KIR3DL1 RECOGNITION OF REMARK 900 THREE IMMUNODOMINANT VIRAL PEPTIDES COMPLEXED REMARK 900 TO HLA-B2705 REMARK 900 RELATED ID: 2VLJ RELATED DB: PDB REMARK 900 THE STRUCTURAL DYNAMICS AND ENERGETICS OF AN REMARK 900 IMMUNODOMINANT T-CELL RECEPTOR ARE REMARK 900 PROGRAMMED BY ITS VBETA DOMAIN REMARK 900 RELATED ID: 1B0R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-A0201 COMPLEXED REMARK 900 WITH A PEPTIDE WITH THE CARBOXYL-TERMINAL REMARK 900 GROUP SUBSTITUTED BY A METHYL GROUP REMARK 900 RELATED ID: 1B0G RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( REMARK 900 HLA-A2.1) COMPLEXED WITH BETA 2- REMARK 900 MICROGLOBULIN AND HUMAN PEPTIDE P1049 REMARK 900 RELATED ID: 1OF2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HLA-B*2709 COMPLEXED REMARK 900 WITH THE VASOACTIVE INTESTINAL PEPTIDE TYPE REMARK 900 1 RECEPTOR (VPAC1) PEPTIDE (RESIDUES 400-408 REMARK 900 ) REMARK 900 RELATED ID: 1HHI RELATED DB: PDB REMARK 900 RELATED ID: 1QSE RELATED DB: PDB REMARK 900 STRUCTURE OF HUMAN A6-TCR BOUND TO HLA- REMARK 900 A2 COMPLEXED WITH ALTERED HTLV-1 TAX REMARK 900 PEPTIDE V7R REMARK 900 RELATED ID: 2AXG RELATED DB: PDB REMARK 900 THE IMMUNOGENICITY OF A VIRAL CYTOTOXIC T REMARK 900 CELL EPITOPE ISCONTROLLED BY ITS MHC-BOUND REMARK 900 CONFORMATION REMARK 900 RELATED ID: 1A9B RELATED DB: PDB REMARK 900 DECAMER-LIKE CONFORMATION OF A NANO-PEPTIDE REMARK 900 BOUND TO HLA-B 3501 DUE TO NONSTANDARD REMARK 900 POSITIONING OF THE C-TERMINUS REMARK 900 RELATED ID: 2BVQ RELATED DB: PDB REMARK 900 STRUCTURES OF THREE HIV-1 HLA-B5703- REMARK 900 PEPTIDE COMPLEXES AND IDENTIFICATION OF REMARK 900 RELATED HLAS POTENTIALLY ASSOCIATED WITH LONG REMARK 900 -TERM NON-PROGRESSION REMARK 900 RELATED ID: 1AGC RELATED DB: PDB REMARK 900 ANTAGONIST HIV-1 GAG PEPTIDES INDUCE REMARK 900 STRUCTURAL CHANGES IN HLA B8 - HIV-1 GAG REMARK 900 PEPTIDE (GGKKKYQL - 7Q MUTATION) REMARK 900 RELATED ID: 1HHJ RELATED DB: PDB REMARK 900 HUMAN CLASS I HISTOCOMPATIBILITY ANTIGEN (HLA REMARK 900 -A 0201) COMPLEX WITH A NONAMERIC PEPTIDE REMARK 900 FROM HIV-1 REVERSE TRANSCRIPTASE (RESIDUES REMARK 900 309-317) REMARK 900 RELATED ID: 1QVO RELATED DB: PDB REMARK 900 STRUCTURES OF HLA-A*1101 IN COMPLEX WITH REMARK 900 IMMUNODOMINANTNONAMER AND DECAMER HIV-1 REMARK 900 EPITOPES CLEARLY REVEAL THEPRESENCE OF A REMARK 900 MIDDLE ANCHOR RESIDUE REMARK 900 RELATED ID: 1S9W RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE ANALYSIS OF NY-ESO-1 REMARK 900 EPITOPE, SLLMWITQC,IN COMPLEX WITH HLA-A2 REMARK 900 RELATED ID: 1KTL RELATED DB: PDB REMARK 900 THE HUMAN NON-CLASSICAL MAJOR REMARK 900 HISTOCOMPATIBILITY COMPLEXMOLECULE HLA-E REMARK 900 RELATED ID: 1A6Z RELATED DB: PDB REMARK 900 HFE (HUMAN) HEMOCHROMATOSIS PROTEIN REMARK 900 RELATED ID: 2CIK RELATED DB: PDB REMARK 900 INSIGHTS INTO CROSSREACTIVITY IN HUMAN REMARK 900 ALLORECOGNITION: THE STRUCTURE OF HLA-B35011 REMARK 900 PRESENTING AN EPITOPE DERIVED FROM CYTOCHROME REMARK 900 P450. REMARK 900 RELATED ID: 2UWE RELATED DB: PDB REMARK 900 LARGE CDR3A LOOP ALTERATION AS A FUNCTION REMARK 900 OF MHC MUTATION REMARK 900 RELATED ID: 1I1F RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN CLASS I MHC ( REMARK 900 HLA-A2.1) COMPLEXED WITH BETA 2- REMARK 900 MICROGLOBULIN AND HIV-RT VARIANT PEPTIDE I1Y REMARK 900 RELATED ID: 2AV7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HTLV-1 TAX PEPTIDE REMARK 900 BOUND TO HUMANCLASS I MHC HLA-A2 WITH REMARK 900 THE K66A MUTATION IN THE HEAVYCHAIN. REMARK 900 RELATED ID: 2X4P RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. REMARK 900 1 BOUND TO A PHOTOCLEAVABLE PEPTIDE REMARK 900 RELATED ID: 2X4U RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. REMARK 900 1 BOUND TO HIV-1 PEPTIDE RT468-476 REMARK 900 RELATED ID: 2X4S RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. REMARK 900 1 BOUND TO A PEPTIDE REPRESENTING THE REMARK 900 EPITOPE OF THE H5N1 (AVIAN FLU) REMARK 900 NUCLEOPROTEIN REMARK 900 RELATED ID: 2X4N RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. REMARK 900 1 BOUND TO RESIDUAL FRAGMENTS OF A REMARK 900 PHOTOCLEAVABLE PEPTIDE THAT IS CLEAVED UPON REMARK 900 UV-LIGHT TREATMENT REMARK 900 RELATED ID: 2X4O RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. REMARK 900 1 BOUND TO HIV-1 ENVELOPE PEPTIDE ENV120- REMARK 900 128 REMARK 900 RELATED ID: 2X4R RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. REMARK 900 1 BOUND TO CYTOMEGALOVIRUS (CMV) PP65 REMARK 900 EPITOPE REMARK 900 RELATED ID: 2X4Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF MHC CLASS I HLA-A2. REMARK 900 1 BOUND TO A PHOTOCLEAVABLE PEPTIDE
REMARK 999 REMARK 999 SEQUENCE REMARK 999 INITIALIZING METHIONINE (B0 AND E0) ADDED TO SEQUENCE. REMARK 999 PRW REPLACES PRO IN CHAINS C AND F.
DBREF 2X4T A 1 275 UNP P01892 1A02_HUMAN 25 299 DBREF 2X4T B 0 0 PDB 2X4T 2X4T 0 0 DBREF 2X4T B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2X4T C 1 9 UNP P06725 PP65_HCMVA 495 503 DBREF 2X4T D 1 275 UNP P01892 1A02_HUMAN 25 299 DBREF 2X4T E 0 0 PDB 2X4T 2X4T 0 0 DBREF 2X4T E 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 2X4T F 1 9 UNP P06725 PP65_HCMVA 495 503
SEQADV 2X4T PRW C 4 UNP P06725 PRO 498 SEE REMARK 999 SEQADV 2X4T PRW F 4 UNP P06725 PRO 498 SEE REMARK 999
SEQRES 1 A 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 275 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 275 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 275 TRP GLU SEQRES 1 B 100 MSE ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MSE SEQRES 1 C 9 ASN LEU VAL PRW MET VAL ALA THR VAL SEQRES 1 D 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 D 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 D 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 D 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 D 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 D 275 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 D 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 D 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 D 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 D 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 D 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 D 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 D 275 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 D 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 D 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 D 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 D 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 D 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 D 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 D 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 D 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 D 275 TRP GLU SEQRES 1 E 100 MSE ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 E 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 E 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 E 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 E 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 E 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 E 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 E 100 LYS ILE VAL LYS TRP ASP ARG ASP MSE SEQRES 1 F 9 ASN LEU VAL PRW MET VAL ALA THR VAL
MODRES 2X4T MSE B 0 MET SELENOMETHIONINE MODRES 2X4T MSE B 99 MET SELENOMETHIONINE MODRES 2X4T MSE E 0 MET SELENOMETHIONINE MODRES 2X4T MSE E 99 MET SELENOMETHIONINE
HET MSE B 0 8 HET MSE B 99 9 HET PRW C 4 8 HET MSE E 0 8 HET MSE E 99 9 HET PRW F 4 8 HET MES E1099 12 HET MES B1099 12 HET GOL D1276 12 HET GOL D1277 6 HET GOL A1276 6
HETNAM GOL GLYCEROL HETNAM MSE SELENOMETHIONINE HETNAM PRW (2R,3R)-4-AMINO-2,3-DIHYDROXYBUTANOIC ACID HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID
FORMUL 7 GOL 3(C3 H8 O3) FORMUL 8 MSE 4(C5 H11 N O2 SE) FORMUL 9 PRW 2(C4 H9 N O4) FORMUL 10 MES 2(C6 H13 N O4 S) FORMUL 11 HOH *229(H2 O)
HELIX 1 1 ILE A 52 GLU A 55 5 4 HELIX 2 2 GLY A 56 ASN A 86 1 31 HELIX 3 3 MET A 138 ALA A 150 1 13 HELIX 4 4 HIS A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLN A 180 1 19 HELIX 6 6 GLY A 252 GLN A 255 5 4 HELIX 7 7 GLY D 56 TYR D 85 1 30 HELIX 8 8 ASP D 137 ALA D 149 1 13 HELIX 9 9 HIS D 151 GLY D 162 1 12 HELIX 10 10 GLY D 162 GLY D 175 1 14 HELIX 11 11 GLY D 175 GLN D 180 1 6 HELIX 12 12 GLN D 224 THR D 228 5 5 HELIX 13 13 GLN D 253 GLN D 255 5 3
SHEET 1 AA 8 GLU A 46 PRO A 47 0 SHEET 2 AA 8 THR A 31 ASP A 37 -1 O ARG A 35 N GLU A 46 SHEET 3 AA 8 ARG A 21 VAL A 28 -1 O ALA A 24 N PHE A 36 SHEET 4 AA 8 HIS A 3 VAL A 12 -1 O ARG A 6 N TYR A 27 SHEET 5 AA 8 THR A 94 VAL A 103 -1 O VAL A 95 N SER A 11 SHEET 6 AA 8 PHE A 109 TYR A 118 -1 N LEU A 110 O ASP A 102 SHEET 7 AA 8 LYS A 121 LEU A 126 -1 O LYS A 121 N TYR A 118 SHEET 8 AA 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 AB 4 LYS A 186 ALA A 193 0 SHEET 2 AB 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AB 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AB 4 ARG A 234 PRO A 235 1 O ARG A 234 N GLN A 242 SHEET 1 AC 4 LYS A 186 ALA A 193 0 SHEET 2 AC 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 AC 4 PHE A 241 PRO A 250 -1 O PHE A 241 N PHE A 208 SHEET 4 AC 4 THR A 228 LEU A 230 -1 O GLU A 229 N ALA A 246 SHEET 1 AD 2 ARG A 234 PRO A 235 0 SHEET 2 AD 2 PHE A 241 PRO A 250 1 O GLN A 242 N ARG A 234 SHEET 1 AE 4 GLU A 222 ASP A 223 0 SHEET 2 AE 4 THR A 214 ARG A 219 -1 O ARG A 219 N GLU A 222 SHEET 3 AE 4 TYR A 257 GLN A 262 -1 O THR A 258 N GLN A 218 SHEET 4 AE 4 LEU A 270 ARG A 273 -1 O LEU A 270 N VAL A 261 SHEET 1 BA 4 LYS B 6 SER B 11 0 SHEET 2 BA 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BA 4 PHE B 62 PHE B 70 -1 O PHE B 62 N GLY B 29 SHEET 4 BA 4 SER B 55 PHE B 56 1 O SER B 55 N TYR B 63 SHEET 1 BB 4 LYS B 6 SER B 11 0 SHEET 2 BB 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 BB 4 PHE B 62 PHE B 70 -1 O PHE B 62 N GLY B 29 SHEET 4 BB 4 GLU B 50 HIS B 51 -1 O GLU B 50 N TYR B 67 SHEET 1 BC 2 SER B 55 PHE B 56 0 SHEET 2 BC 2 PHE B 62 PHE B 70 1 O TYR B 63 N SER B 55 SHEET 1 BD 4 GLU B 44 ARG B 45 0 SHEET 2 BD 4 GLU B 36 LYS B 41 -1 O LYS B 41 N GLU B 44 SHEET 3 BD 4 TYR B 78 ASN B 83 -1 O ALA B 79 N LEU B 40 SHEET 4 BD 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 DA 7 GLU D 46 PRO D 47 0 SHEET 2 DA 7 THR D 31 ASP D 37 -1 O ARG D 35 N GLU D 46 SHEET 3 DA 7 ARG D 21 VAL D 28 -1 O ALA D 24 N PHE D 36 SHEET 4 DA 7 HIS D 3 VAL D 12 -1 O ARG D 6 N TYR D 27 SHEET 5 DA 7 THR D 94 VAL D 103 -1 O VAL D 95 N SER D 11 SHEET 6 DA 7 PHE D 109 TYR D 118 -1 N LEU D 110 O ASP D 102 SHEET 7 DA 7 LYS D 121 ALA D 125 -1 O LYS D 121 N TYR D 118 SHEET 1 DB 4 LYS D 186 HIS D 192 0 SHEET 2 DB 4 GLU D 198 PHE D 208 -1 O THR D 200 N HIS D 192 SHEET 3 DB 4 PHE D 241 PRO D 250 -1 O PHE D 241 N PHE D 208 SHEET 4 DB 4 ARG D 234 PRO D 235 1 O ARG D 234 N GLN D 242 SHEET 1 DC 4 LYS D 186 HIS D 192 0 SHEET 2 DC 4 GLU D 198 PHE D 208 -1 O THR D 200 N HIS D 192 SHEET 3 DC 4 PHE D 241 PRO D 250 -1 O PHE D 241 N PHE D 208 SHEET 4 DC 4 GLU D 229 LEU D 230 -1 O GLU D 229 N ALA D 246 SHEET 1 DD 2 ARG D 234 PRO D 235 0 SHEET 2 DD 2 PHE D 241 PRO D 250 1 O GLN D 242 N ARG D 234 SHEET 1 DE 3 THR D 214 ARG D 219 0 SHEET 2 DE 3 TYR D 257 GLN D 262 -1 O THR D 258 N GLN D 218 SHEET 3 DE 3 LEU D 270 ARG D 273 -1 O LEU D 270 N VAL D 261 SHEET 1 EA 4 LYS E 6 SER E 11 0 SHEET 2 EA 4 ASN E 21 PHE E 30 -1 O ASN E 24 N TYR E 10 SHEET 3 EA 4 PHE E 62 PHE E 70 -1 O PHE E 62 N PHE E 30 SHEET 4 EA 4 SER E 55 PHE E 56 1 O SER E 55 N TYR E 63 SHEET 1 EB 4 LYS E 6 SER E 11 0 SHEET 2 EB 4 ASN E 21 PHE E 30 -1 O ASN E 24 N TYR E 10 SHEET 3 EB 4 PHE E 62 PHE E 70 -1 O PHE E 62 N PHE E 30 SHEET 4 EB 4 GLU E 50 HIS E 51 -1 O GLU E 50 N TYR E 67 SHEET 1 EC 2 SER E 55 PHE E 56 0 SHEET 2 EC 2 PHE E 62 PHE E 70 1 O TYR E 63 N SER E 55 SHEET 1 ED 3 GLU E 36 LYS E 41 0 SHEET 2 ED 3 TYR E 78 ASN E 83 -1 O ALA E 79 N LEU E 40 SHEET 3 ED 3 LYS E 91 LYS E 94 -1 O LYS E 91 N VAL E 82
SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.04 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.05 SSBOND 4 CYS D 101 CYS D 164 1555 1555 2.03 SSBOND 5 CYS D 203 CYS D 259 1555 1555 2.04 SSBOND 6 CYS E 25 CYS E 80 1555 1555 2.03
LINK C MSE B 0 N ILE B 1 1555 1555 1.33 LINK C ASP B 98 N MSE B 99 1555 1555 1.33 LINK C VAL C 3 N1 PRW C 4 1555 1555 1.45 LINK C5 PRW C 4 N MET C 5 1555 1555 1.46 LINK C MSE E 0 N ILE E 1 1555 1555 1.33 LINK C ASP E 98 N MSE E 99 1555 1555 1.33 LINK C VAL F 3 N1 PRW F 4 1555 1555 1.45 LINK C5 PRW F 4 N MET F 5 1555 1555 1.47
CISPEP 1 TYR A 209 PRO A 210 0 9.05 CISPEP 2 HIS B 31 PRO B 32 0 0.94 CISPEP 3 TYR D 209 PRO D 210 0 2.43 CISPEP 4 HIS E 31 PRO E 32 0 1.06 CISPEP 5 MET F 5 VAL F 6 0 -7.30
SITE 1 AC1 7 THR D 233 PHE D 241 GOL D1277 TYR E 26 SITE 2 AC1 7 SER E 57 LYS E 58 TYR E 63 SITE 1 AC2 5 GOL A1276 TYR B 26 SER B 57 LYS B 58 SITE 2 AC2 5 HOH B2015 SITE 1 AC3 9 ARG D 6 MET D 98 GLN D 115 HOH D2064 SITE 2 AC3 9 HOH D2065 HOH D2066 PHE E 56 SER E 57 SITE 3 AC3 9 LYS E 58 SITE 1 AC4 7 ARG D 6 ASP D 29 ASP D 30 HOH D2067 SITE 2 AC4 7 HOH D2068 MES E1099 HOH E2027 SITE 1 AC5 9 ARG A 6 PHE A 8 TYR A 27 ASP A 29 SITE 2 AC5 9 ASP A 30 HOH A2003 HOH A2090 MES B1099 SITE 3 AC5 9 HOH B2026
CRYST1 62.391 85.516 80.394 90.00 90.33 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.016028 0.000000 0.000092 0.00000
SCALE2 0.000000 0.011694 0.000000 0.00000
SCALE3 0.000000 0.000000 0.012439 0.00000